Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Tirzepatide has demonstrated cardiovascular safety in clinical trials, but patients should report symptoms like chest pain, severe shortness of breath, or rapid irregular heartbeat immediately
It is a significant result, but it does not happen automatically just because the dose is correct
A separate In a large cohort of patients with type 2 diabetes, researchers found that GLP-1 use was not associated with a higher incidence of NAION but was linked to another eye condition: diabetic retinopathy
Recently, the Judicial Panel on Multidistrict Litigation (JPML) was asked to add two injuries to the complaintdeep vein thrombosis (blood clots) and NAION (permanent vision loss from eye strokes)
